SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-077415
Filing Date
2010-08-13
Accepted
2010-08-13 17:11:22
Documents
5
Period of Report
2010-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w79559ae8vk.htm 8-K 37350
2 EX-2.1 w79559aexv2w1.htm EX-2.1 376432
3 EX-10.1 w79559aexv10w1.htm EX-10.1 87696
4 EX-10.2 w79559aexv10w2.htm EX-10.2 88345
5 EX-10.3 w79559aexv10w3.htm EX-10.3 51693
  Complete submission text file 0000950123-10-077415.txt   643041
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 101016169
SIC: 2834 Pharmaceutical Preparations